Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $37.5000 (4.75%) ($35.4000 - $38.2000) on Mon. Dec. 21, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.89% (three month average) | RSI | 47 | Latest Price | $37.5000(4.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.2% a day on average for past five trading days. | Weekly Trend | CAPR declines -3.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) ARKK(7%) XLF(7%) EWG(6%) EWI(6%) | Factors Impacting CAPR price | CAPR will decline at least -1.945% in a week (0% probabilities). TLT(-5%) VIXM(-4%) SLV(-3%) GLD(-3%) VCSH(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.945% (StdDev 3.89%) | Hourly BBV | 0 () | Intraday Trend | 5.9% | | | |
|
1 - 5 Day Possible Target | $22.82(-39.15%) | Resistance Level | $38.75 | 5 Day Moving Average | $35.9(4.46%) | 10 Day Moving Average | $36.84(1.79%) | 20 Day Moving Average | $38.75(-3.23%) | To recent high | -19.7% | To recent low | 8.4% | Market Cap | $739m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |